Tau Phosphorylation Sites Work in Concert to Promote Neurotoxicity In Vivo
Open accessAbstract
Tau is a microtubule binding protein implicated in a number of human neurodegenerative disorders, including Alzheimer's disease. Phosphorylation of serine-proline/threonine-proline sites, targeted by proline-directed kinases, coincides temporally with neurodegeneration in the human diseases. Recently, we demonstrated that this unique group of serines and threonines has a critical role in controlling tau toxicity in a Drosophila model of tauopathy. Here, we use a combination of genetic and biochemical approaches to examine these sites individually and to determine which of them is primarily responsible for controlling tau neurotoxicity. Despite the importance placed on individual phosphoepitopes and their contributions to disease pathogenesis, our results indicate that no single phosphorylation residue plays a dominant role in controlling tau toxicity. These findings suggest that serine-proline/threonine-proline sites cooperate to mediate neurodegeneration in vivo.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In vivo fly models of tau toxicity using phosphorylation-resistant tau constructs show equivalent or even increased toxicity when compared with wild-type tau.
“in vivo fly models of tau toxicity using phosphorylation-resistant tau constructs show equivalent or even increased toxicity when compared with wild-type tau (41,42).”
From Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation (2011) · cites this paper as [41]
The Results and Discussion report that fly tau constructs resistant to phosphorylation at individual sites, or at a selected group of five sites, caused toxicity similar to wild-type tau. They do not report increased toxicity for those constructs; the Results instead associate greater toxicity with a phosphomimetic construct and markedly reduced toxicity with mutation of all 14 SP/TP sites. Page numbers were not available in our copy. (LLM, conf=0.89)
Experimental — accuracy not yet measuredWhen either 5 or 11 putative GSK-3β phosphorylation sites were mutated to alanine, tau toxicity either comparable to or more robust than the toxicity induced by wild-type tau was still observed.
“when either 5 (41) or 11 (42) putative GSK-3β phosphorylation sites were mutated to alanine, tau toxicity either comparable to or more robust than the toxicity induced by wild-type tau was still observed.”
From Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation (2011) · cites this paper as [41]
Neuronal phenotypes of tau transgenic Drosophila mimic features of human Alzheimer's disease and associated tauopathies.
“In addition, neuronal phenotypes of tau transgenic Drosophila mimic features of human Alzheimer’s disease and associated tauopathies, including but not limited to aberrant tau phosphorylation13, oxidative stress14, DNA damage15,16, decondensation of constitutive heterochromatin10, synaptic dysfunction17 and activation of the cell cycle in post-mitotic neurons18.”
From Pathogenic tau-induced piRNA depletion promotes neuronal death through transposable element dysregulation in neurodegenerative tauopathies (2018) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480 · see citing works
A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418 · cited 2× · see citing works
“This abnormal hyperphosphorylation of tau induces an increase in the apparent molecular mass of the protein, which is observed in disease states (Lee et al., 1991).”
Augustinack, J. C., Schneider, A., Mandelkow, E.-M., & Hyman, B. T. (2002) · Acta Neuropathologica · doi:10.1007/s004010100423 · Cited by 998 · see citing works
Tauopathy in <i>Drosophila</i> : Neurodegeneration Without Neurofibrillary Tangles
Wittmann, C. W., Wszolek, M. F., Shulman, J. M., Salvaterra, P. M., Lewis, J., Hutton, M., & Feany, M. B. (2001) · Science · doi:10.1126/science.1062382 · Cited by 939 · see citing works
Self-citationGreenberg, S. G., & Davies, P. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.15.5827 · Cited by 732 · see citing works
Noble, W., Planel, E., Zehr, C., Olm, V., Meyerson, J., Suleman, F., Gaynor, K., Wang, L., LaFrancois, J., Feinstein, B., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500466102 · Cited by 709 · see citing works
Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205
Goedert, M., Jakes, R., & Vanmechelen, E. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11484-e · Cited by 608 · see citing works
Matsuo, E. S., Shin, R., Billingsley, M., de Voorde, A. V., O'Connor, M., Trojanowski, J., & Lee, V. (1994) · Neuron · doi:10.1016/0896-6273(94)90264-x · Cited by 588 · see citing works
Monoclonal antibody PHF‐1 recognizes tau protein phosphorylated at serine residues 396 and 404
Otvos, L., Feiner, L., Lang, E., Szendrei, G. I., Goedert, M., & Lee, V. M. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490390607 · Cited by 488 · cited 9× · see citing works
“Using disease-associated phospho-specific antibodies to analyze the phosphorylation status of tau AP5 , we found that reactivity with AT270, PHF1, and Tau1 was unchanged compared with tau WT (Figure 6C).”
InfluentialJackson, G. R., Wiedau-Pazos, M., Sang, T.-K., Wagle, N., Brown, C. A., Massachi, S., & Geschwind, D. H. (2002) · Neuron · doi:10.1016/s0896-6273(02)00706-7 · Cited by 488 · see citing works
Biernat, J., Mandelkow, E. M., Schröter, C., Lichtenberg‐Kraag, B., Steiner, B., Berling, B., Meyer, H., Mercken, M., Vandermeeren, A., & Goedert, M. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05204.x · Cited by 484 · see citing works
Griffin, R. J., Moloney, A., Kelliher, M., Johnston, J. A., Ravid, R., Dockery, P., O'Connor, R., & O'Neill, C. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02949.x · Cited by 459 · see citing works
Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo
Fulga, T. A., Elson-Schwab, I., Khurana, V., Steinhilb, M. L., Spires, T. L., Hyman, B. T., & Feany, M. B. (2007) · Nature Cell Biology · doi:10.1038/ncb1528 · Cited by 452 · see citing works
Self-citationPost-translational modifications of tau protein in Alzheimer’s disease
Gong, C.-X., Liu, F., Grundke-Iqbal, I., & Iqbal, K. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-004-0221-0 · Cited by 437 · see citing works
The Structural Basis of Monoclonal Antibody Alz50's Selectivity for Alzheimer's Disease Pathology
Carmel, G., Mager, E. M., Binder, L. I., & Kuret, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32789 · Cited by 402 · see citing works
Mitotic mechanisms in Alzheimer's disease?
Vincent, I., Rosado, M., & Davies, P. (1996) · The Journal of cell biology · doi:10.1083/jcb.132.3.413 · Cited by 386 · see citing works
Goedert, M., Jakes, R., Crowther, R. A., Cohen, P., Vanmechelen, E., Vandermeeren, M., & Cras, P. (1994) · Biochemical Journal · doi:10.1042/bj3010871 · Cited by 375 · see citing works
Nishimura, I., Yang, Y., & Lu, B. (2004) · Cell · doi:10.1016/s0092-8674(04)00170-9 · Cited by 324 · see citing works
Zheng‐Fischhöfer, Q., Biernat, J., Mandelkow, E., Illenberger, S., Godemann, R., & Mandelkow�, E. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2520542.x · Cited by 322 · see citing works
Oxidative stress mediates tau-induced neurodegeneration in Drosophila
Dias-Santagata, D., Fulga, T. A., Duttaroy, A., & Feany, M. B. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28769 · Cited by 318 · see citing works
Self-citationAn, W.-L., Cowburn, R. F., Li, L., Braak, H., Alafuzoff, I., Iqbal, K., Iqbal, I.-G., Winblad, B., & Pei, J.-J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63687-5 · Cited by 312 · see citing works
Steiner, B., Mandelkow�, E., Biernat, J., Gustke, N., Meyer, H. E., Schmidt, B., Mieskes, G., Söling, H., Drechsel, D. N., & Kirschner, M. W. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07563.x · Cited by 304 · see citing works
Neurodegenerative disorders with extensive tau pathology: A comparative study and review
Feany, M. Β., & Dickson, D. W. (1996) · Annals of Neurology · doi:10.1002/ana.410400204 · Cited by 279 · see citing works
Self-citationTOR-Mediated Cell-Cycle Activation Causes Neurodegeneration in a Drosophila Tauopathy Model
Khurana, V., Lu, Y., Steinhilb, M. L., Oldham, S., Shulman, J. M., & Feany, M. B. (2006) · Current Biology · doi:10.1016/j.cub.2005.12.042 · Cited by 266 · see citing works
Self-citationGSK-3β inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila
Mudher, A., Shepherd, D., Newman, T. A., Mildren, P., Jukes, J. P., Squire, A., Mears, A., Berg, S., MacKay, D., Asuni, A. A., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001483 · Cited by 265 · see citing works
Jicha, G. A., Lane, E., Vincent, I. J., Ötvös, L., Hoffmann, R., & Davies, P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69052087.x · Cited by 264 · see citing works
Baudier, J., & Cole, R. D. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45420-8 · Cited by 263 · see citing works
Genetic modifiers of tauopathy in Drosophila
Shulman, J. M., & Feany, M. B. (2003) · Genetics · doi:10.1093/genetics/165.3.1233 · Cited by 256 · see citing works
Self-citationPhosphate analysis and dephosphorylation of modified tau associated with paired helical filaments.
Księżak-Reding, H., Liu, W.-K., & Shu, H.-Y. C. (1992) · Brain Research · doi:10.1016/0006-8993(92)91476-u · Cited by 237 · see citing works
cAMP-Dependent Protein Kinase Phosphorylations on Tau in Alzheimer’s Disease
Jicha, G. A., Weaver, C. L., Lane, E., Vianna, C., Kress, Y., Rockwood, J. M., & Davies, P. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-17-07486.1999 · Cited by 207 · see citing works
Szendrei, G., Lee, V. M. Y., & Otvos, L. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490340212 · Cited by 204 · see citing works
Scott, C. W., Spreen, R. C., Herman, J. L., Chow, F. P., Davison, M. D., Young, J., & Caputo, C. B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54055-2 · Cited by 200 · see citing works
Alz‐50 Antibody recognizes alzheimer‐related neuronal changes
Hyman, B. T., Hoesen, G. W. V., Wolozin, B. L., Davies, P., Vogt, L. J., & Damasio, A. R. (1988) · Annals of Neurology · doi:10.1002/ana.410230410 · Cited by 176 · see citing works
Kimura, T., Ono, T., Takamatsu, J., Yamamoto, H., Ikegami, K., Kondo, A., Hasegawa, M., Ihara, Y., Miyamoto, E., & Miyakawa, T. (1996) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106875 · Cited by 134 · see citing works
Jicha, G. A., Berenfeld, B., & Davies, P. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990315)55:6 · Cited by 123 · see citing works
S/P and T/P phosphorylation is critical for tau neurotoxicity in <i>Drosophila</i>
Steinhilb, M. L., Dias‐Santagata, D., Mulkearns, E. E., Shulman, J. M., Biernat, J., Mandelkow, E., & Feany, M. B. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21232 · Cited by 107 · see citing works
Self-citationZheng, Y., Li, B., Amin, N. D., Albers, W., & Pant, H. C. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03133.x · Cited by 86 · see citing works
Phosphorylated eukaryotic translation factor 4E is elevated in Alzheimer brain
Li, X., An, W.-L., Alafuzoff, I., Soininen, H., Winblad, B., & Pei, J.-J. (2004) · NeuroReport · doi:10.1097/00001756-200410050-00019 · Cited by 84 · see citing works
Yoshida, H., & Goedert, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04052.x · Cited by 83 · see citing works
Singh, T. J., Haque, N., Grundke, I., & Iqbal, K. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01445-7 · Cited by 83 · see citing works
Garver, T. D., Harris, K. A., Lehman, R. A. W., Lee, V., Trojanowski, J., & Billingsley, M. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63062279.x · Cited by 80 · see citing works
Abnormal tau species are produced during Alzheimer's disease neurodegenerating process
Flament, S., & Delacourte, A. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81337-7 · Cited by 66 · see citing works
Maurage, C.-A., Sergeant, N., Ruchoux, M.-M., Hauw, J.-J., & Delacourte, A. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0608-7 · Cited by 51 · see citing works
Cell type-specific processing of human Tau proteins in Drosophila
Grammenoudi, S., Kosmidis, S., & Skoulakis, E. M. C. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.07.045 · Cited by 29 · see citing works
Shea, T. B., & Cressman, C. M. (1999) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006977127422 · Cited by 19 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Hoover, B. R., Reed, M. N., Su, J., Penrod, R. D., Kotilinek, L. A., Grant, M. K., Pitstick, R., Carlson, G. A., Lanier, L. M., Yuan, L.-L., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.030 · Cited by 1,118 · see citing works
Morris, M., Maeda, S., Vossel, K., & Mucke, L. (2011) · Neuron · doi:10.1016/j.neuron.2011.04.009 · Cited by 899 · see citing works
Animal models of Alzheimer's disease and frontotemporal dementia
Götz, J., & Ittner, L. M. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2420 · Cited by 676 · see citing works
Tau promotes neurodegeneration through global chromatin relaxation
Frost, B., Hemberg, M., Lewis, J., & Feany, M. B. (2014) · Nature Neuroscience · doi:10.1038/nn.3639 · Cited by 519 · see citing works
“chromosome 17 (FTDP-17), confirms tau as a causal factor in neurodegenerative disease pathogenesis 2-4 .”
Self-citationThe importance of tau phosphorylation for neurodegenerative diseases
Noble, W., Hanger, D. P., Miller, C. C. J., & Lovestone, S. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00083 · Cited by 475 · see citing works
Tau association with synaptic vesicles causes presynaptic dysfunction
Zhou, L., McInnes, J., Wierda, K., Holt, M., Herrmann, A. G., Jackson, R. J., Wang, Y.-C., Swerts, J., Beyens, J., Miskiewicz, K., et al. (2017) · Nature Communications · doi:10.1038/ncomms15295 · Cited by 434 · see citing works
Tau Promotes Neurodegeneration via DRP1 Mislocalization In Vivo
DuBoff, B., Götz, J., & Feany, M. B. (2012) · Neuron · doi:10.1016/j.neuron.2012.06.026 · Cited by 377 · see citing works
Self-citationTau Aggregation and Its Interplay with Amyloid-β
Nisbet, R. M., Polanco, J.-C., Ittner, L. M., & Götz, J. (2015) · Acta Neuropathologica · doi:10.1007/s00401-014-1371-2 · Cited by 359 · see citing works
Sun, W., Samimi, H., Gamez, M., Zare, H., & Frost, B. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0194-1 · Cited by 315 · see citing works
Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
Querfurth, H., & Lee, H.-K. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00428-5 · Cited by 288 · see citing works
Oxidative stress in alzheimer’s disease: A review on emergent natural polyphenolic therapeutics
Cassidy, L., Fernandez, F., Johnson, J. B., Naiker, M., Owoola, A. G., & Broszczak, D. A. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.102294 · Cited by 283 · see citing works
Tau-based therapies in neurodegeneration: opportunities and challenges
Li, C., & Götz, J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.155 · Cited by 272 · see citing works
Drosophila melanogaster as a model organism for Alzheimer’s disease
Prüßing, K., Voigt, A., & Schulz, J. B. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-35 · Cited by 271 · see citing works
Drosophila melanogaster in the Study of Human Neurodegeneration
Hirth, F. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791556104 · Cited by 236 · see citing works
Lamin Dysfunction Mediates Neurodegeneration in Tauopathies
Frost, B., Bardai, F. H., & Feany, M. B. (2016) · Current Biology · doi:10.1016/j.cub.2015.11.039 · Cited by 226 · see citing works
Self-citationEffects of in vivo conditions on amyloid aggregation
Owen, M. C., Gnutt, D., Gao, M., Wärmländer, S. K. T. S., Jarvet, J., Gräslund, A., Winter, R., Ebbinghaus, S., & Strodel, B. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00034d · Cited by 179 · see citing works
Chatterjee, S., Sang, T.-K., Lawless, G. M., & Jackson, G. R. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn326 · Cited by 178 · see citing works
Lin, C., Tsai, P.-I., Wu, R., & Chien, C. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1737-10.2010 · Cited by 169 · see citing works
Lysosomal Dysfunction Promotes Cleavage and Neurotoxicity of Tau In Vivo
Khurana, V., Elson‐Schwab, I., Fulga, T. A., Sharp, K. A., Loewen, C. A., Mulkearns-Hubert, E. E., Tyynelä, J., Scherzer, C. R., & Feany, M. Β. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001026 · Cited by 148 · see citing works
Self-citationTau-Based Treatment Strategies in Neurodegenerative Diseases
Schneider, A., & Mandelkow�, E. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.006 · Cited by 142 · see citing works
Tackenberg, C., Grinschgl, S., Trutzel, A., Santuccione, A. C., Frey, M. C., Konietzko, U., Grimm, J., Brandt, R., & Nitsch, R. M. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.129 · Cited by 130 · see citing works
Eckert, A., Nisbet, R. M., Grimm, A., & Götz, J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.013 · Cited by 127 · see citing works
Tau‐targeted treatment strategies in Alzheimer's disease
Götz, J., Ittner, A., & Ittner, L. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01713.x · Cited by 127 · see citing works
EGCG impedes human Tau aggregation and interacts with Tau
Sonawane, S. K., Chidambaram, H., Boral, D., Gorantla, N. V., Balmik, A. A., Dangi, A., Ramasamy, S., Marelli, U. K., & Chinnathambi, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-69429-6 · Cited by 129 · see citing works
Cdk5: Multitasking between physiological and pathological conditions
Lopes, J. P., & Agostinho, P. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.03.006 · Cited by 129 · see citing works
Bamburg, J. R., Minamide, L. S., Wiggan, O., Tahtamouni, L. H., & Kuhn, T. B. (2021) · Cells · doi:10.3390/cells10102726 · Cited by 122 · see citing works
Teixeira, J. P., de Castro, A. A., Soares, F. V., da Cunha, E. F. F., & Ramalho, T. C. (2019) · Molecules · doi:10.3390/molecules24234410 · Cited by 122 · see citing works
Novel targets for Alzheimer's disease treatment
Grill, J., & Cummings, J. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.29 · Cited by 113 · see citing works
Ambegaokar, S. S., & Jackson, G. R. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr432 · Cited by 113 · see citing works
“Cyclin E has been shown previously to modify toxicity in fly models induced by both mutant (241) and wild-type tau (41).”
BackgroundPrion-Like Propagation of Post-Translationally Modified Tau in Alzheimer’s Disease: A Hypothesis
Sonawane, S. K., & Chinnathambi, S. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1111-5 · Cited by 113 · see citing works
Transgenic Drosophila models of Alzheimer’s disease and tauopathies
Iijima‐Ando, K., & Iijima, K. (2009) · Brain Structure and Function · doi:10.1007/s00429-009-0234-4 · Cited by 110 · see citing works
A novel tau‐based rhesus monkey model of Alzheimer's pathogenesis
Beckman, D., Chakrabarty, P., Ott, S. P., Dao, A., Zhou, E., Janssen, W. G. M., Donis‐Cox, K., Muller, S., Kordower, J. H., & Morrison, J. H. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12318 · Cited by 112 · see citing works
Sepulveda-Diaz, J. E., Naini, S. M. A., Huynh, M. B., Ouidja, M. O., Yanicostas, C., Chantepie, S., Villares, J., Lamari, F., Jospin, E., Kuppevelt, T. H. V., et al. (2015) · Brain · doi:10.1093/brain/awv056 · Cited by 108 · see citing works
Tau physiology and pathomechanisms in frontotemporal lobar degeneration
Bodea, L., Eckert, A., Ittner, L. M., Piguet, O., & Götz, J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13600 · Cited by 104 · see citing works
Kosmidis, S., Grammenoudi, S., Papanikolopoulou, K., & Skoulakis, E. M. C. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1490-09.2010 · Cited by 105 · see citing works
Protein folding diseases and neurodegeneration: Lessons learned from yeast
Winderickx, J., Delay, C., Vos, A. D., Klinger, H., Pellens, K., Vanhelmont, T., LEUVEN, F. V., & Zabrocki, P. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.01.020 · Cited by 102 · see citing works
Ali, Y., Ruan, K., & Zhai, R. G. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr449 · Cited by 103 · see citing works
LRRK2 phosphorylates novel tau epitopes and promotes tauopathy
Bailey, R. M., Covy, J. P., Melrose, H. L., Rousseau, L., Watkinson, R., Knight, J. A., Miles, S., Farrer, M. J., Dickson, D. W., Giasson, B. I., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1188-4 · Cited by 103 · see citing works
A novel composite of collagen-hydroxyapatite/kappa-carrageenan
Feng, W., Feng, S., Tang, K., He, X., Jing, A., & Liang, G. (2016) · Journal of Alloys and Compounds · doi:10.1016/j.jallcom.2016.09.234 · Cited by 94 · see citing works
Divergent phosphorylation pattern of tau in P301L tau transgenic mice
Deters, N. A., Ittner, L. M., & Götz, J. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06318.x · Cited by 89 · see citing works
The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics
Pritchard, S. M., Dolan, P. J., Vitkus, A., & Johnson, G. V. W. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01273.x · Cited by 89 · see citing works
Zhu, S., Shala, A., Bezginov, A., Sljoka, A., Audette, G. F., & Wilson, D. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120416 · Cited by 88 · see citing works
The Unfolded Protein Response Protects from Tau Neurotoxicity In Vivo
Loewen, C. A., & Feany, M. Β. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013084 · Cited by 88 · see citing works
Self-citationAzorsa, D. O., Robeson, R. H., Frost, D., hoovet, B. M., Brautigam, G. R., Dickey, C., Beaudry, C., Basu, G. D., Holz, D. R., Hernandez, J. A., et al. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-25 · Cited by 88 · see citing works
Dujardin, S., Colin, M., & Buée, L. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12200 · Cited by 88 · see citing works
Götz, J., Xia, D., Leinenga, G., Chew, Y. L., & Nicholas, H. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00072 · Cited by 85 · see citing works
Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease
Collins, A. E., Saleh, T. M., & Kalisch, B. E. (2022) · Antioxidants · doi:10.3390/antiox11020213 · Cited by 87 · see citing works
Feuillette, S., Miguel, L., Frébourg, T., Campion, D., & Lecourtois, M. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06663.x · Cited by 81 · see citing works
An okadaic acid-induced model of tauopathy and cognitive deficiency
Zhang, Z., & Simpkins, J. W. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.077 · Cited by 81 · see citing works
Animal models reveal role for tau phosphorylation in human disease
Götz, J., Gladbach, A., Pennanen, L., van Eersel, J., Schild, A., David, D. C., & Ittner, L. M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.09.008 · Cited by 79 · see citing works
Melchior, B., Mittapalli, G. K., Lai, C., Duong‐Polk, K., Stewart, J., Güner, B., Hofilena, B. J., Tjitro, A., Anderson, S., Herman, D. S., et al. (2019) · Aging Cell · doi:10.1111/acel.13000 · Cited by 73 · see citing works
Neves, A. F., Camargo, C. J., Premer, C., Hare, J. M., Baumel, B. S., & Pinto, M. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113706 · Cited by 76 · see citing works
Iijima-Ando, K., Zhao, L., Gatt, A., Shenton, C., & Iijima, K. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq068 · Cited by 72 · see citing works
Modeling the complex pathology of Alzheimer's disease in Drosophila
Fernandez-Funez, P., de Mena, L., & Rincon-Limas, D. E. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.05.013 · Cited by 69 · see citing works
Colodner, K. J., & Feany, M. Β. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2491-10.2010 · Cited by 67 · see citing works
Self-citationThe mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer’s disease
Talboom, J. S., Velázquez, R., & Oddo, S. (2015) · npj Aging and Mechanisms of Disease · doi:10.1038/npjamd.2015.8 · Cited by 67 · see citing works
Cdk5 acts as a mediator of neuronal cell cycle re-entry triggered by amyloid-β and prion peptides
Lopes, J. P., Oliveira, C. R., & Agostinho, P. M. (2009) · Cell Cycle · doi:10.4161/cc.8.1.7506 · Cited by 66 · see citing works
Rapamycin suppresses brain aging in senescence-accelerated OXYS rats
Kolosova, N. G., Vitovtov, A. O., Muraleva, N. A., Евгеньевич, А. А., Stefanova, N. A., & Blagosklonny, M. V. (2013) · Aging · doi:10.18632/aging.100573 · Cited by 65 · see citing works
Schmitt, C., Kail, D., Mariano, M., Empting, M., Weber, N., Paul, T., Hartmann, R. W., & Engel, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087851 · Cited by 64 · see citing works
Intracellular and Extracellular Roles for Tau in Neurodegenerative Disease
Hanger, D. P., Lau, D. H. W., Phillips, E. C., Bondulich, M. K., Guo, T., Woodward, B. W., Pooler, A. M., & Noble, W. J. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132054 · Cited by 62 · see citing works
Protein Tau: Prime Cause of Synaptic and Neuronal Degeneration in Alzheimer's Disease
Crespo‐Biel, N., Theunis, C., & LEUVEN, F. V. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/251426 · Cited by 64 · see citing works
Intracellular and extracellular tau
Ávila, J. (2010) · Frontiers in Neuroscience · doi:10.3389/fnins.2010.00049 · Cited by 63 · see citing works
Drosophila Models of Tauopathies: What Have We Learned?
Gistelinck, M., Lambert, J., Callaerts, P., Dermaut, B., & Dourlen, P. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/970980 · Cited by 58 · see citing works
Keeney, J. T. R., Swomley, A. M., Harris, J. L., Fiorini, A., Mitov, M. I., Marzia Perluigi, A., Rukhsana Sultana, A., & Butterfield, D. A. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9287-2 · Cited by 56 · see citing works
Jiang, M., Zhang, X., Yan, X., Mizutani, S., Kashiwazaki, H., Ni, J., & Wu, Z. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.08.213 · Cited by 58 · see citing works
An, F.-M., Chen, S., Xu, Z., Yin, L., Wang, Y., Liu, A.-R., Yao, W.-B., & Gao, X.-D. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.023 · Cited by 55 · see citing works
Implicating Calpain in Tau-Mediated Toxicity In Vivo
Reinecke, J. B., DeVos, S. L., McGrath, J. P., Shepard, A. M., Goncharoff, D. K., Tait, D. N., Fleming, S. R., Vincent, M. P., & Steinhilb, M. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023865 · Cited by 52 · see citing works
Self-citationZhao, Z., Zhao, Y., Ning, Y.-L., Yang, N., Peng, Y., Li, P., Chen, X.-Y., Liu, D., Wang, H., Chen, X., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.98 · Cited by 52 · see citing works
Epigallocatechin-3-gallate modulates Tau Post-translational modifications and cytoskeletal network
Sonawane, S. K., & Chinnathambi, S. (2021) · Oncotarget · doi:10.18632/oncotarget.27963 · Cited by 51 · see citing works
Ávila, J. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00214.x · Cited by 51 · see citing works
Drosophila Models of Proteinopathies: the Little Fly that Could
Rincón-Limas, D. E., Jensen, K., & Fernández-Fúnez, P. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799315894 · Cited by 51 · see citing works
Phospho-Tau Changes in the Human CA1 During Alzheimer’s Disease Progression
Regalado-Reyes, M., Furcila, D., Hernández, F., Ávila, J., DeFelipe, J., & León‐Espinosa, G. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181263 · Cited by 46 · see citing works
Important neuronal toxicity of microtubule-bound Tau in vivo in Drosophila
Talmat-Amar, Y., Arribat, Y., Redt‐Clouet, C., Feuillette, S., Bougé, A.-L., Lecourtois, M., & Parmentier, M. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr290 · Cited by 46 · see citing works
Yu, L., Chen, Y., Wang, W., Xiao, Z.-H., & Hong, Y. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160329 · Cited by 45 · see citing works
Alzheimer's Disease and tauopathy studies in flies and worms
Wentzell, J. S., & Kretzschmar, D. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.03.007 · Cited by 43 · see citing works
Tau excess impairs mitosis and kinesin-5 function, leading to aneuploidy and cell death
Bougé, A.-L., & Parmentier, M. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.022558 · Cited by 44 · see citing works
γ-Aminobutyric Acid Type A (GABAA) Receptor Activation Modulates Tau Phosphorylation
Nykänen, N.-P., Kysenius, K., Sakha, P., Tammela, P., & Huttunen, H. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.309385 · Cited by 43 · see citing works
Ando, K., Oka, M., Ohtake, Y., Motoki, H., Shimizu, S., Hisanaga, S., & Iijima, K. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.053 · Cited by 40 · see citing works
Li, L., Liang, J., & Fu, H. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.10.020 · Cited by 41 · see citing works
Tau Aggregates and Tau Pathology
Hernández, F., & Ávila, J. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14414 · Cited by 42 · see citing works
Combinatorial Tau Pseudophosphorylation
Kiris, E., Ventimiglia, D., Sargin, M. E., Gaylord, M. R., Altınok, A., Rose, K. H., Manjunath, B. S., Jordan, M. A., Wilson, L., & Feinstein, S. C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.219311 · Cited by 40 · see citing works
Blocking Effects of Human Tau on Squid Giant Synapse Transmission and Its Prevention by T-817 MA
Moreno, H., Choi, S., Yu, E., Brusco, J., Ávila, J., Moreira, J. E., Sugimori, M., & Llinás, R. R. (2011) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2011.00003 · Cited by 39 · see citing works
Hannan, S. B., Dräger, N. M., Rasse, T. M., Voigt, A., & Jahn, T. R. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13532 · Cited by 38 · see citing works
Beharry, C., Alaniz, M. E., & Alonso, A. D. C. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130617 · Cited by 39 · see citing works
Animal Models for Alzheimer’s Disease and Frontotemporal Dementia: A Perspective
Götz, J., & Götz, N. N. (2009) · ASN NEURO · doi:10.1042/an20090042 · Cited by 37 · see citing works
mNos2Deletion and HumanNOS2Replacement in Alzheimer Disease Models
Colton, C. A., Wilson, J. G., Everhart, A. L., Wilcock, D. M., Puoliväli, J. T., Heikkinen, T., Oksman, J., Jääskeläinen, O., Lehtimäki, K. K., Laitinen, T., et al. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000094 · Cited by 37 · see citing works
Bardai, F. H., Wang, L., Mutreja, Y., Yenjerla, M., Gamblin, T. C., & Feany, M. B. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.1550-17.2017 · Cited by 37 · see citing works
Self-citationIs Tau Aggregation Toxic or Protective: A Sensible Question in the Absence of Sensitive Methods?
Götz, J., Ittner, L. M., Fändrich, M., & Schönrock, N. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14410 · Cited by 37 · see citing works
Leugers, C. J., Koh, J. Y., Hong, W., & Lee, G. S. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00161 · Cited by 34 · see citing works
How it all Started: Tau and Protein Phosphatase 2A
Liu, C., & Götz, J. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130503 · Cited by 35 · see citing works
Hickey, J. P., Collins, A. E., Nelson, M. L., Chen, H., & Kalisch, B. E. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46050266 · Cited by 35 · see citing works
Povellato, G., Tuxworth, R. I., Hanger, D. P., & Tear, G. (2013) · Biology Open · doi:10.1242/bio.20136692 · Cited by 33 · see citing works
Papanikolopoulou, K., & Skoulakis, E. M. C. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddu726 · Cited by 33 · see citing works
Wu, T.-H., Lu, Y., Chuang, C.-L., Wu, C., Chiang, A., Krantz, D. E., & Chang, H.-Y. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1105-x · Cited by 33 · see citing works
Recent advances in using Drosophila to model neurodegenerative diseases
Lu, B. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0347-5 · Cited by 31 · see citing works
Modeling Tauopathy in the Fruit Fly Drosophila melanogaster
Khurana, V. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15403 · Cited by 31 · see citing works
Uno, Y., Iwashita, H., Tsukamoto, T., Uchiyama, N., Kawamoto, T., Kori, M., & Nakanishi, A. (2009) · Brain Research · doi:10.1016/j.brainres.2009.08.034 · Cited by 30 · see citing works
Ambegaokar, S. S., & Jackson, G. R. (2010) · Genetics · doi:10.1534/genetics.110.119545 · Cited by 30 · see citing works
Giong, H.-K., Subramanian, M., Yu, K., & Lee, J.-S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168465 · Cited by 29 · see citing works
Tseng, J., Ajit, A., Tabassum, Z., Patel, N., Tian, X., Chen, Y., Prevatte, A. W., Ling, K., Rigo, F., Meeker, R. B., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2021.109037 · Cited by 26 · see citing works
- Authors
- Steinhilb, M. L., Dias-Santagata, D., Fulga, T. A., Felch, D. L., & Feany, M. B.
- Affiliations
- Central Michigan University (US)
- Brigham and Women's Hospital (US)
- Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; and
- Venue
- Molecular Biology of the Cell
- Published
- 2007-12
- Volume
- 18
- Issue
- 12
- Pages
- 5060-5068
- ISSN
- 1059-1524 (ISSN-L)
- 1939-4586
- PMC
- PMC2096612
- OpenAlex
- W2165049228
- Cited by
- 187
- References
- 46
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 7 · 2023: 6 · 2022: 5 · 2021: 16 · 2020: 5 · 2019: 13 · 2018: 4 · 2017: 11 · 2016: 7 · 2015: 14 · 2014: 15 · 2013: 14 · 2012: 9
- FWCI
- 8.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular Biology of the Cell (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (AG-19790, P50AG005134, AG 05134, R01AG019790)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- tau phosphorylation, proline-directed kinases, tauopathy, Alzheimer's disease, Drosophila model, neurodegeneration, microtubule-binding protein
- MeSH terms
- Amino Acids, Animals, Cell Cycle, Drosophila melanogaster, Electrophoresis, Polyacrylamide Gel, Mutation, Neurons, Phosphorylation, Protein Kinases, Signal Transduction, tau Proteins, Phosphatidylinositol 3-Kinases, Drosophila Proteins, Animals, Genetically Modified, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
